Evidence map›Paper›PMID 28304392›Full record

ReviewNature reviews. Endocrinology2017

Metrics for glycaemic control - from HbA

Boris P Kovatchev

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04203927 (Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes), which is not on this map. Cited by 121 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 2 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04203927 early_phase1unknown statusstarted 2020, after this paper: background citation

Effects of Empagliflozin on Cardiac Microvasculature and Insulin Sensitivity in Subjects With Type 2 Diabetes

Ran2020Enrolled50Registered outcomes4Posted comparisons0ConditionsInsulin Sensitivity, Type2 DiabetesArmsempagliflozin 25 mg
PMID 29166232PMID 26981940PMID 25633683PMID 27299675PMID 24711523PMID 23459195PMID 21617098PMID 21047922PMID 20978231PMID 20380649PMID 19996061PMID 16386091other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 2 syntheses or guidelines pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Review

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Boris P KovatchevUniversity of Virginia School of Medicine, 1215 Lee Street, Charlottesvile, Virginia 22908, USA.
University of Virginia · US

Funding

DYNAMIC RISK MEASURES FOR SEVERE HYPOGLYCEMIAR01DK051562 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MARC D BRETON · 1996 to 2023
$2.4M
NIDDK NIH HHS R01 DK051562
6 · The paper itself

Abstract

As intensive treatment to lower levels of HbA

Indexed as

AlgorithmsBiomarkersBlood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusGlycated HemoglobinHumansBiomarkersBlood GlucoseGlycated Hemoglobin

Identifiers

PMID28304392
OpenAlexW2596063051

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.